Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
ZR-75-1
HR+
Luminal
Pevonedistat
NAE1
NAE1
12003.135
uM
0.78281
0.50730
0.1934 0.0727 0.3619 0.3755
0.9268
0.9898
ZR-75-1
HR+
Luminal
Tozasertib
AURK/FLT3/ABL/JAK2
AURK
11660.15
uM
2.44570
66.64330
-0.0071 -1.0000 0.3324 0.2920
0.8631
0.9958
ZR-75-1
HR+
Luminal
Erlotinib
EGFR
ErbB
7553.091
uM
inf
inf
0.9665 0.9665 0.0000 -0.0228
-0.3323
0.9738
ZR-75-1
HR+
Luminal
MG-132
Proteasome
Proteasome
11660.145
uM
0.47233
1.21540
-0.8693 -0.8719 1.0678 0.5829
0.9976
0.9169
ZR-75-1
HR+
Luminal
Doxorubicin
TOP2
TOP
7932.043
uM
0.12271
0.25988
-0.7083 -0.5033 0.9281 0.6673
0.9471
0.9982
ZR-75-1
HR+
Luminal
Gemcitabine
DNA replication
DNA replication
7932.011
uM
0.02338
0.02080
-0.0531 0.1219 2.3909 0.5838
0.9535
0.9025
ZR-75-1
HR+
Luminal
2-deoxyglucose
12677.177
uM
inf
inf
0.3935 0.3935 0.0000 0.2078
0.3077
1.0515
ZR-75-1
HR+
Luminal
Sunitinib
PDGFR/VEGFR/KIT/FLT3
RTK
7552.067
uM
10.03460
12.54540
-0.9796 -0.9797 4.8587 0.3735
0.9983
1.0224
ZR-75-1
HR+
Luminal
Valproic acid
HDAC
HDAC
11660.143
uM
739.35260
1000.00000
-0.7032 -0.2500 1.3425 0.2387
0.7593
1.0389
ZR-75-1
HR+
Luminal
Z-Leu-Leu-Norvalinal
Proteasome
Proteasome
14296.189
uM
1.89760
2.50260
-0.9364 -0.9212 3.7751 0.5470
0.9892
0.6639
ZR-75-1
HR+
Luminal
Nilotinib
ABL
nRTK
12003.145
uM
inf
inf
0.9728 0.9728 0.0000 0.0104
0.0000
0.9611
ZR-75-1
HR+
Luminal
Bortezomib
Proteasome
Proteasome
7552.074
uM
0.13222
0.32325
-0.7900 -0.7103 0.9889 0.7952
0.9760
0.9174
ZR-75-1
HR+
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
12003.167
uM
1.41090
10.49420
-0.3709 -1.0000 0.5475 0.3641
0.9076
1.1158
ZR-75-1
HR+
Luminal
Triciribine
AKT
AKT
7553.074
uM
10.22730
73.93430
0.2175 -1.0000 0.5554 0.1841
0.8701
0.9515
ZR-75-1
HR+
Luminal
Bromopyruvic acid
Hexokinase II
Metabolism
12677.177
uM
0.10357
0.14167
-0.9831 -0.9756 3.4545 0.8644
0.9986
1.0515
ZR-75-1
HR+
Luminal
Cetuximab
EGFR
ErbB
7931.042
uM
inf
inf
0.8278 0.8278 0.0000 -0.0111
0.4074
1.3878
ZR-75-1
HR+
Luminal
Lestaurtinib
FLT3/JAK2/TrkA
RTK
11660.154
uM
1.28590
10.59590
-0.3306 -1.0000 0.5209 0.3588
0.9488
0.9388
ZR-75-1
HR+
Luminal
Oxamflatin
HDAC
HDAC
12003.147
uM
1.75560
8.28140
-0.8786 -1.0000 0.7082 0.4604
0.8990
1.1884
ZR-75-1
HR+
Luminal
PD184352
MEK
MAPK
11660.146
uM
583.9090
1000.00000
0.4704 -0.0361 0.1295 0.2471
0.6207
0.9684
ZR-75-1
HR+
Luminal
FR180204
ERK1/2
MAPK
11660.149
uM
inf
inf
0.7903 0.7903 0.0000 0.1532
0.0592
1.0690
ZR-75-1
HR+
Luminal
Bosutinib
Src
nRTK
11660.145
uM
5.16470
8.72860
-0.9838 -0.9998 2.0932 0.4186
0.9930
0.9169
ZR-75-1
HR+
Luminal
AG1478
EGFR
ErbB
7932.016
uM
175.56330
175.46780
0.5616 0.0014 4.9999 0.0271
0.7988
0.6446
ZR-75-1
HR+
Luminal
Vinorelbine
TUBB
TUBB
7932.052
uM
0.02137
0.17670
-0.8958 -0.7487 0.4333 0.7300
0.8880
0.8877
ZR-75-1
HR+
Luminal
FTase Inhibitor I
Ftase
MAPK
12003.167
uM
inf
inf
0.7304 0.7304 0.0000 0.2250
-0.0343
1.1158
ZR-75-1
HR+
Luminal
ICRF-193
TOP2
TOP
11660.151
uM
inf
inf
0.6460 0.6460 0.0000 0.1792
0.5635
0.9483